BioMatthew is a member of the Healthcare sector team. He has been involved in a number of transactions, including Amdipharm and Mercury Pharma (merged to create AMCo), Medpace, NPS, Pronet, Sebia, STADA, Labco and Synlab (merged under the Synlab brand) and Ufinet.
Prior to joining Cinven, Matthew worked in the Investment Banking Division of Citigroup in London, advising on M&A and restructuring deals across a range o ....
Work Experience
Current
Past